SG11201407857SA - Composition, in an aqueous medium, including at least one hyaluronic acid and at least one sucrose octasulphate water-soluble salt - Google Patents
Composition, in an aqueous medium, including at least one hyaluronic acid and at least one sucrose octasulphate water-soluble saltInfo
- Publication number
- SG11201407857SA SG11201407857SA SG11201407857SA SG11201407857SA SG11201407857SA SG 11201407857S A SG11201407857S A SG 11201407857SA SG 11201407857S A SG11201407857S A SG 11201407857SA SG 11201407857S A SG11201407857S A SG 11201407857SA SG 11201407857S A SG11201407857S A SG 11201407857SA
- Authority
- SG
- Singapore
- Prior art keywords
- composition
- water
- aqueous medium
- hyaluronic acid
- soluble salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261659140P | 2012-06-13 | 2012-06-13 | |
| FR1255543A FR2991876B1 (en) | 2012-06-13 | 2012-06-13 | COMPOSITION, IN AQUEOUS MEDIUM, COMPRISING AT LEAST ONE HYALURONIC ACID AND AT LEAST ONE WATER-SOLUBLE SALT OF SUCROSE OCTASULFATE |
| PCT/FR2013/051380 WO2013186493A2 (en) | 2012-06-13 | 2013-06-13 | Composition, in an aqueous medium, including at least one hyaluronic acid and at least one sucrose octasulphate water-soluble salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201407857SA true SG11201407857SA (en) | 2015-02-27 |
Family
ID=46785648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201407857SA SG11201407857SA (en) | 2012-06-13 | 2013-06-13 | Composition, in an aqueous medium, including at least one hyaluronic acid and at least one sucrose octasulphate water-soluble salt |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9314530B2 (en) |
| EP (1) | EP2861301B1 (en) |
| JP (1) | JP6178414B2 (en) |
| KR (1) | KR20150023468A (en) |
| CN (1) | CN104394934B (en) |
| AU (1) | AU2013276343B2 (en) |
| BR (1) | BR112014029510A2 (en) |
| CA (1) | CA2876057A1 (en) |
| EA (1) | EA201492208A1 (en) |
| ES (1) | ES2728686T3 (en) |
| FR (1) | FR2991876B1 (en) |
| IL (1) | IL235776A0 (en) |
| MX (1) | MX354544B (en) |
| PL (1) | PL2861301T3 (en) |
| SG (1) | SG11201407857SA (en) |
| TR (1) | TR201907427T4 (en) |
| WO (1) | WO2013186493A2 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9492474B2 (en) | 2013-07-10 | 2016-11-15 | Matrix Biology Institute | Compositions of hyaluronan with high elasticity and uses thereof |
| US9421198B2 (en) | 2013-07-30 | 2016-08-23 | Teoxane | Composition comprising hyaluronic acid and mepivacaine |
| FR3015290B1 (en) * | 2013-12-23 | 2017-01-13 | Lab Vivacy | HYALURONIC ACID COMPOSITIONS COMPRISING MEPIVACAINE |
| CN106659663A (en) * | 2014-06-30 | 2017-05-10 | 纽璀克斯技术公司 | Combination products and cosmetic compositions for controlling skin disorders and skin aging that affect keratinocytes and/or fibroblasts and the dermis |
| FR3032617B1 (en) * | 2015-02-16 | 2018-03-16 | Kylane Laboratoires Sa | PROCESS FOR THE PREPARATION OF AN INJECTABLE HYDROGEL; HYDROGEL OBTAINED; USE OF THE HYDROGEL OBTAINED |
| US10004824B2 (en) | 2015-05-11 | 2018-06-26 | Laboratoires Vivacy | Compositions comprising at least one polyol and at least one anesthetic |
| FR3036035B1 (en) | 2015-05-11 | 2018-10-05 | Laboratoires Vivacy | COMPOSITIONS COMPRISING AT LEAST ONE POLYOL AND AT LEAST ONE ANESTHETIC |
| CN104926889A (en) * | 2015-05-24 | 2015-09-23 | 广西师范学院 | Sucrose sulfate copper and silver compound as well as preparation method and application thereof |
| RU2020123728A (en) | 2015-09-24 | 2021-01-18 | Матрикс Байолэджи Инститьют | COMPOSITIONS OF HYALURONIC ACID WITH HIGH ELASTIC PROPERTIES AND METHODS OF THEIR APPLICATION |
| FR3044557B1 (en) * | 2015-12-07 | 2017-12-01 | Benedicte Vincente Gavard Molliard Tauzin | NOVEL COMPOSITION INJECTABLE; PROCESS FOR THE PREPARATION OF SAID COMPOSITION; USE OF SAID COMPOSITION |
| WO2017102001A1 (en) | 2015-12-16 | 2017-06-22 | Vplus International Sa | Hyaluronic acid composition for penile injections |
| FR3047666A1 (en) * | 2016-02-15 | 2017-08-18 | Benedicte Vincente Gavard Molliard Tauzin | INJECTABLE COMPOSITION; PROCESS FOR THE PREPARATION OF SAID COMPOSITION; USE OF SAID COMPOSITION |
| FR3058064B1 (en) | 2016-10-28 | 2020-08-07 | Lab Vivacy | COMPOSITION BASED ON HYALURONIC ACID INCLUDING MEPIVACAINE |
| JP2020503377A (en) | 2016-12-13 | 2020-01-30 | ベータ セラピューティクス プロプライアタリー リミティド | Heparanase inhibitors and uses thereof |
| US11787783B2 (en) | 2016-12-13 | 2023-10-17 | Beta Therapeutics Pty Ltd | Heparanase inhibitors and use thereof |
| EP3554505A4 (en) * | 2016-12-13 | 2020-09-16 | Beta Therapeutics Pty. Ltd. | Methods of treating ocular disorders |
| FR3109153B1 (en) | 2020-04-10 | 2022-07-15 | Teoxane SA | Compositions based on at least two glycosaminoglycans |
| KR102664134B1 (en) * | 2023-11-23 | 2024-05-10 | 한국콜마주식회사 | Cosmetic composition with hyaluronic acid and derivatives thereof |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2715091A (en) | 1949-11-28 | 1955-08-09 | Nat Res Dev | Dextran sulfate as anticoagulant, process of preparing same, and sterile solution thereof |
| AU607690B2 (en) | 1985-12-24 | 1991-03-14 | Marion Laboratories, Inc. | Use of synthetic sulfated saccharides to enhance wound healing |
| US5916880A (en) | 1987-12-21 | 1999-06-29 | Bukh Meditec A/S | Reduction of skin wrinkling using sulphated sugars |
| DK505488D0 (en) | 1987-12-21 | 1988-09-09 | Bar Shalom Daniel | MEDIUM AND USE OF SAME |
| DK86492D0 (en) | 1992-06-30 | 1992-06-30 | Bukh Meditec | PHARMACEUTICAL PRODUCT |
| WO1998022114A1 (en) | 1996-11-15 | 1998-05-28 | Dumex-Alpharma A/S | A method for promoting tissue repair |
| JP2000178196A (en) * | 1998-12-11 | 2000-06-27 | Seikagaku Kogyo Co Ltd | Novel hyaluronidase inhibitor and preparation for external use |
| GB9902412D0 (en) | 1999-02-03 | 1999-03-24 | Fermentech Med Ltd | Process |
| CA2451248A1 (en) * | 2001-06-25 | 2003-01-03 | Depuy International Limited | Composition comprising glycosaminoglycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| US20050187150A1 (en) * | 2001-10-31 | 2005-08-25 | New York University | Structure-based design and synthesis of FGF inhibitors and FGF modulator compounds |
| MXPA01011542A (en) | 2001-11-13 | 2003-05-22 | Alcon Inc | Regeneration of articular cartilage damaged by osteoarthritis i and ii, by means of intra-articular application of sodium hyaluronate and chondroitin sulphate in a gel carrier. |
| AUPS052802A0 (en) | 2002-02-15 | 2002-03-07 | Praxis Pharmaceuticals International Pty Ltd | Carbohydrate-based anti-wrinkle and tissue remodelling compounds |
| US20080003258A1 (en) | 2002-10-16 | 2008-01-03 | Marcum Frank D | Composition and Method for Treating Rheumatoid Arthritis |
| ES2374157T3 (en) | 2002-10-16 | 2012-02-14 | Arthrodynamic Technologies, Animal Health Division, Inc. | TREATMENT FOR TRAUMATIC SYNOVITIS AND DAMAGED ARTICULAR CARTRIDGE. |
| FR2861734B1 (en) | 2003-04-10 | 2006-04-14 | Corneal Ind | CROSSLINKING OF LOW AND HIGH MOLECULAR MASS POLYSACCHARIDES; PREPARATION OF INJECTABLE SINGLE PHASE HYDROGELS; POLYSACCHARIDES AND HYDROGELS OBTAINED |
| GB0329907D0 (en) | 2003-12-23 | 2004-01-28 | Innomed Ltd | Compositions |
| FR2865737B1 (en) | 2004-02-03 | 2006-03-31 | Anteis Sa | BIOCOMPATIBLE RETICLE GEL |
| US20090215717A1 (en) | 2004-08-05 | 2009-08-27 | Ivax Drug Research Institute Ltd. | Sulfated oligosaccharides |
| BRPI0515191A (en) * | 2004-08-13 | 2008-07-08 | Angiotech Internac Ag | pharmaceutical composition, method for augmenting bone or replacing bone loss, method for reducing pain associated with postoperative scarring, method for preventing surgical adhesion, method for enlarging or repairing skin or tissue, method for maintaining eye fluid volume during eye surgery , method for reducing pain associated with osteoarthritis, method for treating gastroesophageal reflux disease, method for treating or preventing urinary incontinence, method for treating or preventing fecal incontinence, implant method and medical device |
| US20080050335A1 (en) | 2006-07-25 | 2008-02-28 | Osmotica Corp. | Ophthalmic Solutions |
| WO2008020495A1 (en) * | 2006-08-15 | 2008-02-21 | Tokyo Cemical Industry Co., Ltd. | Novel inhibitor |
| FR2918276B1 (en) | 2007-07-02 | 2010-01-22 | Anteis Sa | "USE OF A NATURAL POLYSACCHARIDE (S) GEL FOR THE PREPARATION OF AN INJECTION FORMULATION FOR THE TREATMENT OF JOINT DEGENERESCENCES" |
| ITMI20072237A1 (en) | 2007-11-27 | 2009-05-28 | Sigea Srl | MIXED BUTIRRIC-FORMAL ESTERS OF ACID POLYSACCHARIDES, THEIR PREPARATION AND USE AS DERMOCOSMETICS |
| US8394784B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
| FR2924615B1 (en) | 2007-12-07 | 2010-01-22 | Vivacy Lab | HYDROGEL COHESIVE BIODEGRADABLE. |
| FR2953522B1 (en) | 2009-12-07 | 2012-03-09 | Fabre Pierre Dermo Cosmetique | SUCROSE ZINC OCTASULFATES, THEIR PREPARATION AND THEIR PHARMACEUTICAL AND COSMETIC APPLICATIONS |
| US20110171310A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
| FR2956322A1 (en) | 2010-02-17 | 2011-08-19 | Urgo Lab | USE OF SYNTHETIC POLYSULFATE OLIGOSACCHARIDES AS DETERSION AGENTS OF A WOUND. |
| US9017712B2 (en) * | 2010-07-12 | 2015-04-28 | Shin Poong Pharmaceutical Co., Ltd. | Filler composition for tissue reinforcement |
| FR2983483B1 (en) | 2011-12-02 | 2014-11-14 | Vivacy Lab | PROCESS FOR SIMULTANEOUS SUBSTITUTION AND RETICULATION OF A POLYSACCHARIDE VIA ITS HYDROXYL FUNCTIONS |
-
2012
- 2012-06-13 FR FR1255543A patent/FR2991876B1/en active Active
-
2013
- 2013-06-12 US US13/916,236 patent/US9314530B2/en active Active
- 2013-06-13 AU AU2013276343A patent/AU2013276343B2/en active Active
- 2013-06-13 TR TR2019/07427T patent/TR201907427T4/en unknown
- 2013-06-13 EA EA201492208A patent/EA201492208A1/en unknown
- 2013-06-13 JP JP2015516668A patent/JP6178414B2/en active Active
- 2013-06-13 WO PCT/FR2013/051380 patent/WO2013186493A2/en active Application Filing
- 2013-06-13 CA CA2876057A patent/CA2876057A1/en not_active Abandoned
- 2013-06-13 KR KR20147036186A patent/KR20150023468A/en not_active Application Discontinuation
- 2013-06-13 BR BR112014029510A patent/BR112014029510A2/en not_active IP Right Cessation
- 2013-06-13 MX MX2014013949A patent/MX354544B/en active IP Right Grant
- 2013-06-13 PL PL13733396T patent/PL2861301T3/en unknown
- 2013-06-13 ES ES13733396T patent/ES2728686T3/en active Active
- 2013-06-13 SG SG11201407857SA patent/SG11201407857SA/en unknown
- 2013-06-13 CN CN201380031227.6A patent/CN104394934B/en active Active
- 2013-06-13 EP EP13733396.9A patent/EP2861301B1/en active Active
-
2014
- 2014-11-18 IL IL235776A patent/IL235776A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013276343A1 (en) | 2014-12-04 |
| US20140005140A1 (en) | 2014-01-02 |
| MX354544B (en) | 2018-03-09 |
| CN104394934A (en) | 2015-03-04 |
| EA201492208A1 (en) | 2015-04-30 |
| FR2991876B1 (en) | 2014-11-21 |
| WO2013186493A3 (en) | 2014-05-08 |
| KR20150023468A (en) | 2015-03-05 |
| FR2991876A1 (en) | 2013-12-20 |
| US9314530B2 (en) | 2016-04-19 |
| WO2013186493A2 (en) | 2013-12-19 |
| CN104394934B (en) | 2018-01-09 |
| JP2015525099A (en) | 2015-09-03 |
| EP2861301A2 (en) | 2015-04-22 |
| ES2728686T3 (en) | 2019-10-28 |
| IL235776A0 (en) | 2015-01-29 |
| AU2013276343B2 (en) | 2017-06-15 |
| MX2014013949A (en) | 2015-05-11 |
| BR112014029510A2 (en) | 2017-06-27 |
| JP6178414B2 (en) | 2017-08-09 |
| TR201907427T4 (en) | 2019-06-21 |
| EP2861301B1 (en) | 2019-02-20 |
| PL2861301T3 (en) | 2020-08-24 |
| CA2876057A1 (en) | 2013-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201407857SA (en) | Composition, in an aqueous medium, including at least one hyaluronic acid and at least one sucrose octasulphate water-soluble salt | |
| IL282239A (en) | Antisense-induced exon2 inclusion in acid alpha-glucosidase | |
| PL2834320T3 (en) | New aqueous fracturing fluid composition and fracturing method implementing the fluid | |
| EP2959009A4 (en) | Tracking changes in average glycemia in diabetics | |
| EP2862909A4 (en) | Aqueous coating composition and coating method using same | |
| IL237370A0 (en) | Aqueous food composition enriched in β-glucan | |
| EP3065722A4 (en) | Nucleic acid nanostructures for in vivo agent delivery | |
| EP2971030B8 (en) | Oligosaccharide compositions, glycoproteins and methods to produce the same in prokaryotes | |
| EP2948418A4 (en) | Fertilizer composition and method for suspending fertilizer in an aqueous solution | |
| EP2885774A4 (en) | Improvements in, or relating to, tamper evident systems | |
| EP3023410A4 (en) | 5-BROMINE-2-(alpha-HYDROXYPENTYL)BENZOIC ACID SODIUM SALTS IN DIFFERENT CRYSTAL FORMS, AND PREPARATION METHOD THEREOF | |
| SG2014009740A (en) | An aqueous dispersible polymer composition | |
| ZA201307467B (en) | An aqueous dispersible polymer composition | |
| HK1187335A1 (en) | Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals 3-- | |
| HK1210941A1 (en) | Modified hyaluronic acid derivatives and use thereof | |
| EP2832346A4 (en) | Aqueous dispersed composition | |
| PL2934473T3 (en) | Cleansing preparations with exfoliating action, based on water-soluble constituents in crystalline form | |
| PL2866588T3 (en) | Nanogel comprising water-soluble active ingredients | |
| HK1220984A1 (en) | Sulfated polygulonic acid polysaccharide or pharmaceutical salt thereof, preparation method therefor and use thereof | |
| IL236027A0 (en) | Grenade,in particular 40 mm grenade | |
| AU2012902375A0 (en) | Low sodium salt |